Navigation Links
Grifols Starts Construction of a New Plasma Fractionation Plant in Barcelona (Parets Del Valles)
Date:2/18/2011

BARCELONA, Spain, Feb. 18, 2011 /PRNewswire/ -- Grifols, the Spanish group which specializes in the hospital-pharmaceutical sector and is one of the world's leading producers of plasma products, will shortly start construction of a new plant representing an investment of 20 million euros that will employ about 100 people, as soon as it obtains local permits and licenses. The new facilities will have the capacity to fractionate 1 million liters of plasma a year (with potential to expand to 2 million), allowing the group to double its existing fractionation capacity in Spain. The Grifols plant in Los Angeles, California, currently has a capacity of 2.2 million liters, giving the group total capacity of 6.3 million liters in 2014.

The construction work is scheduled to take 18 months, after which the process of obtaining licenses from the FDA (Food & Drug Administration) in the United States and from the EMA (European Medicines Agency) will begin. This is expected to take no more than two years, as the new plant will fractionate plasma through to the intermediate product stage. The purification, inactivation and sterile filling stages for the different proteins will be performed at Grifols' existing facilities at Parets del Valles, which have already been adapted to absorb this increased level of production.

The new plant will use the very latest technology and will make maximum use of automation. Grifols Engineering S.A., a group company which specializes in the engineering of biotechnological and pharmaceutical processes, has designed the new facilities and will manage the construction project. The plant will also serve as a model for the future construction of another fractionation plant in the United States (San Marcos, Texas) due to start in 2014, and delivering a maximum capacity of 4 million liters.

The new plant forms part of the 433 million euro investment plan for the period 2008-2012, approved at the end of 2007 by the Board of
'/>"/>

SOURCE Grifols
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Health Robotics CytoCare(TM) Global Expansion Continues With Grifols International in Latin America
2. AMDL Diagnostics, Inc. Enters Into Exclusive Distribution Agreement With Grifols USA, LLC to Advance Commercialization of DR-70 Onko-Sure(TM) Cancer Test
3. Grifols Agrees to Acquire Intellectual Property for Treatment of Post-Polio Syndrome From Pharmalink AB
4. Health Robotics CytoCare Continues European Expansion With Grifols and Vall dHebron University Hospital
5. NASDAQ Removes TLCR From Biotechnology Index Pending FTC Decision on Grifols Acquisition
6. New Company Starts, Bridging the Development Gap in the Discovery of Cancer Drugs
7. VIDEO: Femara(R) helps protect against return of breast cancer even when treatment starts several years after completing tamoxifen therapy
8. Impliant Restarts Pivotal Clinical Trial for Patented TOPS(TM) Spine System
9. BN ImmunoTherapeutics Starts Clinical Trials With Prostate Cancer Vaccine
10. U.S. NCI Starts Enrolment in Phase 2 Systemic Melanoma Clinical Trial with REOLYSIN(R)
11. Presbyterian Hospital Dallas Starts Advanced Breast-Cancer Risk-Assessment Program
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2014)... Calif. , Aug. 27, 2014  After the ... and Personal Injury billing solution for medical practices ... positive response toward the new software. "The ... Sandy Thompson . "The sheer number of demos ... true the need was for these types of software ...
(Date:8/27/2014)... -- Zimmer Holdings, Inc. (NYSE and SIX: ZMH), a global ... participating in the Morgan Stanley 2014 Global Healthcare Conference ... New York , on Tuesday, September 9, 2014.  ... will be presenting at 9:10 a.m. Eastern Time.  ... join Mr. Dvorak for the Q&A session. ...
(Date:8/27/2014)... 2014 Sinovac Biotech Ltd. (NASDAQ: SVA ), ... , today announced the results of the Company,s 2014 Annual General ... Beijing , PRC. The required quorum, a majority of ... The Company,s shareholders approved the following proposals:  , The ... Simon Anderson , Kenneth Lee and Meng ...
Breaking Medicine Technology:Medical Software Company, Prime Clinical Systems, Sees Excellent Response to their Workers' Compensation Solutions 2Medical Software Company, Prime Clinical Systems, Sees Excellent Response to their Workers' Compensation Solutions 3Sinovac Announces Results of 2014 Annual General Meeting of Shareholders 2
... 2011 Ingenious Med, the leading platform for automated ... now available on the App Store for iPhone, iPod ... part of the company,s presence at the Hospital Information ... Ingenious Med,s 9,000 users to access the charge and ...
... Feb. 17, 2011 NexBio, Inc. announced the presentation ... a Patient after Allogeneic Stem Cell Transplantation" at the ... February 17-21 in Honolulu, Hawaii.  The data was presented ... General Hospital and Harvard Medical School. Parainfluenza ...
Cached Medicine Technology:HIMSS11: Ingenious Med Launches Billing and Data Capture App for iPhone, iPod touch and iPad 2NexBio’s DAS181 (Fludase®*) Improved Symptoms in a Severely Immunocompromised Patient with Parainfluenza Pneumonitis 2NexBio’s DAS181 (Fludase®*) Improved Symptoms in a Severely Immunocompromised Patient with Parainfluenza Pneumonitis 3
(Date:8/27/2014)... Aspirus Wausau Hospital today announced the first ... Digital O.R. at Aspirus Wausau Hospital, in Wausau, WI. ... rooms will be Buzz, a centralized surgical hub for ... planning, navigation, imaging and communications connectivity. , Buzz ... and hardware all controlled from the full HD 42” ...
(Date:8/27/2014)... UNIWIGS, one of the leading purveyors of real and synthetic ... sales on all its products, for the coming Labor Day. , ... UniWigs hair products in two ways: when they spend ... a coupon code LABOR10; while when they spend more than $299, ... deal which coupon code is needed when securely checkout, there are ...
(Date:8/27/2014)... Hepatocellular carcinoma (HCC) is the second leading cause ... are due to the difficulty in treating this ... epirubicin, cisplatin, 5-fluorouracil, etoposide or combinations therein. This ... are not able to reach in a sufficient ... that are not harmful to the rest of ...
(Date:8/27/2014)... Fluorochemicals are synthetically produced chemicals, which repel water ... and chemical conditions in industrial processing. These characteristics ... and products, such as coatings for food paper ... that they are difficult to break down and ... fluorochemicals have known correlations with harmful health effects, ...
(Date:8/27/2014)... 27, 2014 DISCcert has scheduled its ... place Sept 10th, 17th, 24th, and Oct 1st from ... receive a certification seal that will allow them to ... consists of four weekly one-hour webinar sessions. In between ... are offered individual coaching time. , Trainers, participating ...
Breaking Medicine News(10 mins):Health News:Aspirus Wausau Hospital Announces First Large Scale Digital Operating Room Integration Project in the US 2Health News:Aspirus Wausau Hospital Announces First Large Scale Digital Operating Room Integration Project in the US 3Health News:UniWigs Is Offering A Big Sale for Labor Day on All Its Products 2Health News:The thunder god vine, assisted by nanotechnology, could shake up future cancer treatment 2Health News:The thunder god vine, assisted by nanotechnology, could shake up future cancer treatment 3Health News:Leading scientists call for a stop to non-essential use of fluorochemicals 2Health News:Leading scientists call for a stop to non-essential use of fluorochemicals 3Health News:Online DISC Certification Webinar Series to Begin Sept 10 Announces DISCcert 2Health News:Online DISC Certification Webinar Series to Begin Sept 10 Announces DISCcert 3Health News:Online DISC Certification Webinar Series to Begin Sept 10 Announces DISCcert 4
... researcher Dr. Daniel Von Hoff, a member of ... in-depth look at the "lost opportunity" in phase ... companies use the phase I trial to evaluate ... advocates that it can also provide valuable efficacy ...
... have made several, subtle changes in the structure of a ... according to a study published in a December edition of ... have profound implications for the treatment of hemophilia, the inherited ... Americans. , In most cases, hemophilia is ...
... those with lupus, rheumatoid arthritis , , MONDAY, Dec. 22 ... cells, but these cells stay in an "off" state, ... the body cause autoimmune diseases such as lupus and ... adults are true precursors of the self-attacking immune cells ...
... common this time of year , , MONDAY, Dec. 22 ... holidays this year, with many people both blue and ... jobless rate in three decades and a jackknifing stock market. ... often during the winter months not only because of the ...
... fresh start for career-building in today,s tough economic times. The ... professions. , ... (PRWEB) December 22, ... a recruiting campaign targeting career changers and other potential students. ...
... 2008, Cambridge, UK Scientists report that human gene mutations ... Disease, a fatal nervous system disorder that begins during childhood. ... (DMM), dmm.biologists.org , describes how the extent of ... in humans. ,The initial, milder symptoms of Batten ...
Cached Medicine News:Health News:Renowned Cancer Researcher Dan Von Hoff, M.D. Advocates for 'The Lost Opportunity in Phase I Oncology Trials' 2Health News:Renowned Cancer Researcher Dan Von Hoff, M.D. Advocates for 'The Lost Opportunity in Phase I Oncology Trials' 3Health News:Renowned Cancer Researcher Dan Von Hoff, M.D. Advocates for 'The Lost Opportunity in Phase I Oncology Trials' 4Health News:Redesigned protein accelerates blood clotting 2Health News:Redesigned protein accelerates blood clotting 3Health News:Redesigned protein accelerates blood clotting 4Health News:Blue and Broke for the Holidays 2Health News:Blue and Broke for the Holidays 3Health News:Blue and Broke for the Holidays 4Health News:Parker College of Chiropractic Education Launches Recruiting Campaign for Career Changers and Potential Students 2
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: